Skip to main content
Livermore
Livermore
ZHEN

SpringWorks Therapeutics, Inc.

SWTXDelisted Jul 1, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001773427

SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.

Holders of 5% or more of SWTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of SpringWorks Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SWTX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Vanguard Group Inc13G/A9.62%7.16M shares–Feb 10, 20224 filingsJan 31, 2025SEC
Hudson Bay Capital Management LP13G5.22%3.94M sharesNewAug 8, 20251 filingAug 8, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

40 Schedule 13D and 13G filings on SpringWorks Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SWTX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 12, 20253:34 PM ETGoldman Sachs Group Incand 1 other13G/A0.00%132 shares−5.60 ppfrom 5.60%Below 5%Sep 30, 2025SEC
Aug 13, 20255:25 PM ETGoldman Sachs Group Incand 1 other13G5.60%4.23M sharesNewJun 30, 2025SEC
Aug 8, 20254:24 PM ETHudson Bay Capital Management LPand 1 other13G5.22%3.94M sharesNewJun 30, 2025SEC
Jul 7, 20254:04 PM ETGlazer Capital, LLCand 1 other13G0.00%0 sharesNewBelow 5%Jun 30, 2025SEC
May 7, 202511:01 AM ETFMR LLCand 1 other13G/A1.70%1.26M shares–Below 5%Apr 30, 2025SEC
Feb 14, 20258:44 AM ETDeep Track Capital, LPand 2 others13G/A4.65%3.46M shares–Below 5%Dec 31, 2024SEC
Jan 31, 20259:55 AM ETVanguard Group Inc13G/A9.62%7.16M shares–Dec 31, 2024SEC
Oct 25, 2024Boxer Capital Management, LLC13G/AOld format–––SEC
Feb 14, 2024Deep Track Capital, LP13G/AOld format–––SEC
Feb 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Jan 26, 202411:49 AM ETBlackRock Inc.13G/AOld format–––SEC
Jan 23, 2024State Street Corp13G/AOld format–––SEC
Dec 6, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
May 17, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Apr 14, 2023Deep Track Capital, LP13GOld format–New–SEC
Mar 20, 2023BC SW, LP13D/AOld format–––SEC
Feb 14, 2023Perceptive Advisors LLC13G/AOld format–––SEC
Feb 10, 2023State Street Corp13GOld format–New–SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Feb 7, 202312:59 PM ETBlackRock Inc.13GOld format–New–SEC
Jan 5, 2023OrbiMed Advisors LLC13D/AOld format–––SEC
Sep 19, 2022Boxer Capital, LLC13GOld format–New–SEC
Sep 16, 2022EcoR1 Capital, LLC13GOld format–New–SEC
Sep 14, 2022OrbiMed Advisors LLC13D/AOld format–––SEC
Sep 13, 2022BC SW, LP13D/AOld format–––SEC
Apr 11, 2022FMR LLC13G/AOld format–––SEC
Feb 15, 2022Perceptive Advisors LLC13G/AOld format–––SEC
Feb 14, 2022Pfizer Inc13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13GOld format–New–SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Aug 12, 2021BC SW, LP13D/AOld format–––SEC
Mar 11, 2021BC SW, LP13D/AOld format–––SEC
Mar 4, 2021OrbiMed Advisors LLC13D/AOld format–––SEC
Feb 16, 2021Perceptive Advisors LLC13G/AOld format–––SEC
Feb 12, 2021Pfizer Inc13G/AOld format–––SEC
Feb 11, 2021Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 8, 2021FMR LLC13GOld format–New–SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell SpringWorks Therapeutics, Inc. shares, newest first.

Form 144 notices for SWTX
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jun 20, 20235:01 PM ETJulie HambletonBoard Member4.82K$130.1KJun 20, 202310b5-1J.P. Morgan Securities LLCSEC